PsyBio Therapeutics
€0.001500
0
+€0.00+0%Monday 20:00
Statistics
Day High
0.0015
Day Low
0.0015
52W High
0.0015
52W Low
0.0015
Volume
11,000
Avg. Volume
0
Mkt Cap
121,347
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-4.62MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Sunrise, FL.
Show More
CEO
Evan Levine
Employees
118
Country
Canada
ISIN
CA6936971044
WKN
000A2QQYS
Listings
0 Comments
Share your thoughts
FAQs
What is PsyBio Therapeutics stock price today?▼
The current price of PSYB.MU is €0.00 EUR — it has increased by +0% in the past 24 hours. Watch PsyBio Therapeutics stock price performance more closely on the chart.
What is PsyBio Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange PsyBio Therapeutics stocks are traded under the ticker PSYB.MU.
What is PsyBio Therapeutics market cap?▼
Today PsyBio Therapeutics has the market capitalization of 121,347
What is PsyBio Therapeutics revenue for the last year?▼
PsyBio Therapeutics revenue for the last year amounts to 0 EUR.
What is PsyBio Therapeutics net income for the last year?▼
PSYB.MU net income for the last year is -4.62M EUR.
How many employees does PsyBio Therapeutics have?▼
As of November 2, 2026, the company has 118 employees.
In which sector is PsyBio Therapeutics located?▼
PsyBio Therapeutics operates in the Health & Wellness sector.
When did PsyBio Therapeutics complete a stock split?▼
PsyBio Therapeutics has not had any recent stock splits.
Where is PsyBio Therapeutics headquartered?▼
PsyBio Therapeutics is headquartered in Denver, Canada.